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The crystal structure of a  -lactamase-like protein from Brucella melitensis was
initially solved by SAD phasing from an in-house data set collected on a crystal
soaked with iodide. A high-resolution data set was collected at a synchroton at
the Se edge wavelength, which also provided an independent source of phasing
using a small anomalous signal from metal ions in the active site. Comparisons of
anomalous peak heights at various wavelengths allowed the identiﬁcation of the
active-site metal ions as manganese. In the native data set a partially occupied
GMP could be identiﬁed. When co-crystallized with AMPPNP or GMPPNP,
clear density for the hydrolyzed analogs was observed, providing hints to the
function of the protein.
1. Introduction
The mission of the Seattle Structural Genomics Center for Infectious
Disease (SSGCID) is to provide the scientiﬁc community with a
library of crystal structures of proteins from infectious organisms that
are potential drug targets. This collection of structures is hoped to
promote structure-guided drug design against National Institutes for
Allergy and Infectious Disease (NIAID) class A, B and C infectious
disease organisms. The target organisms are divided between
SSGCID and its sister organization the Center for Structural Geno-
mics of Infectious Diseases (CSGID). Both centers provide plasmids
(BEI repository), protein samples (SSGCID), coordinates and
structure factors (Protein Data Bank), and raw diffraction images
(http://www.csgid.org/csgid/pages/diffraction_images) to the commu-
nity immediately after completion of a target.
Brucella melitensis is a Gram-negative bacterial pathogen and one
of the several Brucella species identiﬁed to cause brucellosis (Moreno
& Moriyon, 2002). Brucellosis affects mostly goats, sheep and cattle,
causing reproductive diseases such as abortions and stillbirths, hence
the popular name ‘contagious abortion’. The pathogen can be
transmitted to humans via contact with infected animals or the con-
sumption of unpasteurized milk or cheese (Young, 1995). In humans
the disease was initially called ‘Malta fever’ or ‘undulating fever’ and
is multi-systemic, with nonspeciﬁc symptoms such as fever, chills,
dementia, fatigue, headaches, nausea, vomiting, muscular and bodily
pain. Regions with signiﬁcant impact of brucellosis are parts of the
Mediterranean, Asia, Africa and Latin America (Corbel, 1997).
Infections can be successfully treated with antimicrobial agents. The
pathobiology of Brucella is unique owing to the absence of classical
virulence factors (Moreno & Moriyon, 2002).
Here, we report the high-resolution structure of BrabA.11339.a, a
structural genomics target that entered the pipeline as a ‘ -lactamase-
like protein’.  -Lactamases break down  -lactam antibiotics such as
penicillin and lead to the resistance of pathogens to antibiotics. There
are four classes of  -lactamase: classes A–D. While classes A, C and
D have an active site-serine, class B metallo- -lactamases have a
binuclear metal center in the active site that activates a water. With
high-resolution data including anomalous information at various
wavelengths, we could obtain a detailed description of the active site
of BrabA.11339.a and an identiﬁcation of the active-site metals.Ligand-bound structures lead us towards an understanding of the
function of this protein.
2. Materials and methods
2.1. Cloning, expression and purification
The gene for BrabA.11339.a from B. melitensis biovar Abortus
2308 (NCBI YP_414422.1; locus BAB1_1016; UniProt Q2YQ74)
spanning the full-length protein from residues 2–272 was cloned into
a pAVA0421 vector using ligation-independent cloning (LIC;
Aslanidis & de Jong, 1990; Mehlin et al., 2006). The vector encodes an
N-terminal histidine-afﬁnity tag followed by the substrate sequence
for 3C protease; the entire tag sequence is MAHHHHHHMGTLE-
AQTQ0GPGS, where 0 indicates the cleavage site.
The protein was expressed in Escherichia coli using BL21 (DE3)
R3 Rosetta cells and autoinduction medium (Studier, 2005) in a LEX
Bioreactor. Starter cultures of LB broth with appropriate antibiotics
were grown for  18 h at 310 K. ZYP-5052 auto-induction medium
was freshly prepared as per Studier’s published protocol (Studier,
2005). Antibiotics were added to 2 l bottles of sterile auto-induction
medium. The bottles were inoculated with all of the overnight culture.
Inoculated bottles were then placed into a LEX bioreactor. Cultures
were grown for  24 h at 298 K; the temperature was reduced to
288 K and the cultures were grown for a further  60 h. To harvest,
the medium was centrifuged at 4000g for 20 min at 277 K. The cell
paste was ﬂash-frozen in liquid nitrogen and stored at 193 K.
The frozen cells were resuspended in lysis buffer (25 mM HEPES
pH 7.0, 500 mM NaCl, 5% glycerol, 30 mM imidazole, 0.025% sodium
azide, 0.5% CHAPS, 10 mM MgCl2,1 m M TCEP, 250 ng ml
 1
AEBSFand 0.05 mgm l
 1 lysozyme). The resuspended cell pellet was
disrupted on ice for 30 min with a Virtis sonicator (408912) set to
100 W power with alternating cycles of 15 s pulse-on and 15 s pulse-
off. The cell debris was incubated with 20 ml Benzonase nuclease
(25 units ml
 1) at room temperature for 45 min and clariﬁed by cen-
trifugation using a Sorvall SLA-1500 centrifuge at 14 000 rev min
 1
for 75 min at 277 K. The protein was puriﬁed from the clariﬁed cell
lysate by immobilized metal-afﬁnity chromatography using a 5 ml
HisTrap FF column (GEHealthcare) equilibrated with binding buffer
(25 mM HEPES pH 7.0, 500 mM NaCl, 5% glycerol, 30 mM imida-
zole, 0.025% sodium azide, 1 mM TCEP). The recombinant protein
was eluted with 250 mM imidazole. The hexahistidine tag was
removed by overnight incubation with 3C protease. The sample was
then passed over HisTrap resin in a gravity-ﬂow column. The tagless
protein was collected in the ﬂowthrough. It was further puriﬁed
by size-exclusion chromatography (SEC) using a HiLoad 26/60
Superdex 75 column (GE Healthcare) equilibrated with SEC buffer
(25 mM HEPES pH 7.0, 500 mM NaCl, 2 mM DTT, 0.025% sodium
azide and 5% glycerol). The protein eluted as a single peak. The peak
fractions were pooled and concentrated to 19.6 mg ml
 1 using an
Amicon Ultra centrifugal ﬁlter with a 10 kDa cutoff (Millipore). The
concentrated sample was ﬂash-frozen in liquid nitrogen and stored at
193 K.
2.2. Crystallization and X-ray data collection
For the target BrabA.11339.a at a protein concentration of
19.6 mg ml
 1, two sparse-matrix screens were set up following the
strategy of Newman et al. (2005): JCSG+ (Emerald BioSystems) and
PACT (Molecular Dimensions). 0.4 ml protein solution was mixed
with 0.4 ml well solution and equilibrated against 100 ml reservoir
using 96-well Compact Jr crystallization plates (Emerald Bio-
Systems). Crystals suitable for diffraction studies were obtained
under two very similar conditions from the PACT screen: G9
(200 mM sodium/potassium tartrate, 100 mM Bis-Tris propane pH
7.5, 20% PEG 3350) and H9 (200 mM sodium/potassium tartrate,
100 mM Bis-Tris propane pH 8.5, 20% PEG 3350). Crystals were
cryoprotected in a buffer consisting of well solution to which 20%
ethylene glycol was added.
A native data set was collected in-house at Cu K  wavelength
using a Rigaku SuperBright FR-E
+ rotating-anode X-ray generator
equipped with Osmic VariMax HF optics and a Saturn 944+ CCD
detector (Table 1, native Cu K ). The diffraction data were reduced
with XDS/XSCALE (Kabsch, 2010) and scaled to 1.85 A ˚ resolution
in space group C2221.
In order to obtain experimental phase information, a crystal from
the same well was incubated for 5 min in an iodide-containing buffer
consisting of 200 mM sodium/potassium tartrate, 100 mM HEPES pH
7.0, 25% PEG 3350, 250 mM KI. A data set with high multiplicity was
collected in-house using the same set up as described above. 720
images were collected with a width per frame of 0.5 . The diffraction
data were reduced with XDS/XSCALE (Kabsch, 2010) and scaled
to 2.0 A ˚ resolution. Data analysis in XSCALE (Anomalous Corre-
lation and SigAno) indicated a strong anomalous signal out to 2.0 A ˚
resolution.
A high-resolution data set was collected on beamline 5.0.1 of the
Berkeley Center for Structural Biology in the context of the Colla-
borative Crystallography program. The wavelength of this beamline
is optimized for an Se-SAD experiment: 0.9774 A ˚ /12.4 keV (Morton
et al., 2007). The beamline is equipped with a 3   3 tiled ADSC Q315r
detector. The diffraction data were reduced with XDS/XSCALE
(Kabsch, 2010) and scaled to 1.27 A ˚ resolution. A weak anomalous
signal can be detected in the XSCALE data analysis.
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Table 1
Data-collection statistics.
Values in parentheses are for the highest of 20 resolution shells.
Ligand Iodide Native Cu K  Native ALS 501 GMP Cu K  AMP Cu K  AMPALS 502
Wavelength (A ˚ ) 1.5418 1.5418 0.9774 1.5418 1.5418 1.3476
Space group C2221 C2221 C2221 C2221 C2221 C2221
Unit-cell parameters (A ˚ ) a = 72.71, b = 74.95,
c = 98.27
a = 72.63, b = 75.04,
c = 98.11
a = 72.89, b = 75.25,
c = 98.36
a = 72.86, b = 75.23,
c = 98.54
a = 72.85, b = 75.20,
c = 98.53
a = 73.21, b = 75.53,
c = 98.94
Resolution range (A ˚ ) 50–2.00 (2.05–2.00) 50–1.85 (1.90–1.85) 50–1.27 (1.30–1.27) 50–1.70 (1.74–1.70) 50–1.70 (1.74–1.70) 50–1.60 (1.64–1.60)
Unique reﬂections 17854 (1257) 23011 (1520) 71257 (5123) 29984 (2068) 29964 (2069) 36362 (2574)
Multiplicity 12.4 (6.9) 5.4 (1.90) 9.5 (6.7) 9.1 (4.4) 9.1 (4.5) 12.4 (6.1)
Completeness (%) 99.3 (94.3) 98.9 (91.3) 99.7 (97.2) 99.5 (93.1) 99.5 (93.6) 99.6 (95.9)
Rmerge† 0.072 (0.140) 0.048 (0.149) 0.051 (0.489) 0.037 (0.147) 0.041 (0.203) 0.069 (0.390)
Mean I/ (I) 27.1 (11.4) 24.7 (5.1) 28.3 (3.9) 40.0 (9.2) 35.2 (7.7) 25.1 (5.8)
† Rmerge =
P
h
P
i jIiðhÞ h IðhÞij=
P
h
P
i IiðhÞ.In order to validate ligand binding, the protein was incubated with
1m M AMPPNPor GMPPNP and 2 mM MgCl2. A small optimization
screen was set up: 15–20% PEG 3350, 200 mM sodium/potassium
tartrate, 100 mM Bis-Tris pH 7.0–8.0. After crystals had grown to full
size within a few days, they were incubated for 1 min in a cryopro-
tection buffer consisting of 1 mM AMPPNP or GMPPNP, 2 mM
MgCl2, 15% ethylene glycol, 21% PEG 3350, 165 mM sodium/
potassium tartrate, 83 mM Bis-Tris pH 7.5. For each of the co-crystals,
a data set with high multiplicity was collected at the home source as
described for the iodide soak above. Each data set was scaled to 1.7 A ˚
resolution. For another AMPPNP cocrystal from the same optimi-
zation screen, a data set with high multiplicity was collected at a
wavelength of 1.3476 A ˚ on beamline 5.0.2 of the Berkeley Center for
Structural Biology in the context of the Collaborative Crystal-
lography program. The wavelength was selected to be at lower energy
than the Zn edge (1.284 A ˚ /9.659 keV) but at signiﬁcantly higher
energy than the Mn edge (1.896 A ˚ /6.359 keV) The ALS beamline is
equipped with a 3   3 tiled ADSC Q315r detector. The data were
scaled to 1.6 A ˚ resolution.
2.3. Structure solution and refinement
The packing density of the crystals (Matthews, 1968),
VM = 2.2 A ˚ 3 Da
 1 (44% solvent content), suggested one molecule of
BrabA.11339.a per asymmetric unit. A search of the Protein Data
Bank with BLAST (Altschul et al., 1997) did not yield any structural
homologs beyond 23% sequence identity. Attempts to solve the
structure of BrabA.11339.a by molecular replacement with Phaser
(McCoy et al., 2007) using the initial native data set (native Cu K ,
1.85 A ˚ resolution) and PDB entry 3g1p (23% identity; K. Podze-
linska, S. He, M. Wathier, A. Yakunin, M. Proudfoot, B. Hove-Jensen,
D. Zechel & Z. Jia, unpublished work) as search models were not
successful. Experimental phases were obtained independently from
both the iodide soak and the high-resolution synchrotron data set.
2.3.1. Iodide data set. Data analysis with XSCALE indicated a
strong anomalous signal to 2.0 A ˚ resolution. phenix.hyss (Grosse-
Kunstleve & Adams, 2003) was used to locate 11 anomalous
scatterers in the data set from the iodide soak. The anomalous sub-
structure was reﬁned with Phaser (McCoy et al., 2007), which then
extended the anomalous substructure to 16 sites and yielded a ﬁgure
of merit (FOM) of 0.49 to 2.0 A ˚ resolution. The experimental phases
obtained from Phaser were improved with the CCP4 program Parrot
(Cowtan, 2010). An initial model (256 residues, Rwork = 0.307) was
built with ARP/wARP (Langer et al., 2008), followed by iterative
rounds of manual real-space ﬁtting in Coot (Emsley et al., 2010) and
reciprocal-space reﬁnement with REFMAC5 (Murshudov et al.,
2011).
2.3.2. Native synchrotron data set. In a separate approach, the
native high-resolution synchrotron data set was used to phase the
BrabA.11339.a structure. The XSCALE analysis had indicated a
moderate anomalous signal to  2.0 A ˚ resolution. phenix.hyss
(Grosse-Kunstleve & Adams, 2003) was able to locate two strong
anomalous scatterers when the diffraction data were limited to 3 A ˚
resolution. Phaser (McCoy et al., 2007) reﬁned and extended the
anomalous substructure to three atoms and yielded an FOM of 0.360
using data to 1.8 A ˚ resolution. After density improvement with
Parrot (Cowtan, 2010), ARP/wARP (Langer et al., 2008) could build a
good initial model with 267 residues and a Rwork of 0.200 with data to
1.7 A ˚ resolution.
The model for the high-resolution structure of BrabA.11339.a
contains one protein molecule spanning residues Ser3–Val272,
two manganese ions, a potassium ion, a sodium ion, a guanosine
5-monophosphate (GMP), a tartrate molecule and 348 water mole-
cules. The ﬁnal structure was validated with Coot (Cowtan, 2010) and
MolProbity (Chen et al., 2010). The structure was deposited in the
PDB with the identiﬁer 3md7 (see Table 2).
The three structures cocrystallized with AMPPNP or GMPPNP
were solved by direct reﬁnement of the high-resolution structure
from which all nonprotein atoms had been removed. Data and
reﬁnement statistics are summarized in Tables 1 and 2.
3. Results and discussion
The target BrabA.11339.a entered the SSGCID pipeline as a
‘ -lactamase-like’ protein from B. melitensis. A search of sequence
databases for homologies yielded a variety of annotations, primarily
other ‘ -lactamase-like’ proteins, metal-dependent hydrolases, un-
characterized proteins, PhnP (a phosphodiesterase of the carbon–
phosphorus lyase pathway for phosphonate degradation) proteins
and tRNase Z proteins. However, the sequence is highly conserved
between various species, with many proteins sharing more than 50%
sequence identity. A search of the Protein Data Base yielded a
striking lack of structures with high sequence homology. The phos-
phodiesterase of the carbon–phosphorus lyase pathway (PhnP; PDB
entry 3g1p) from E. coli is the closest homologue; PhnP shares 23%
sequence identity with BrabA.11339.a, with a large number of inserts
and deletions.
structural communications
1108 Abendroth et al.   BrabA.11339.a Acta Cryst. (2011). F67, 1106–1112
Table 2
Reﬁnement and model statistics.
The models for the iodide and nativeCu K  data sets have only been partially reﬁned. Preliminary reﬁnement statistics are shown in italics. Values in parentheses are for the highest of 20
resolution shells.
Ligand Iodide Native Cu K  Native ALS 501 GMP Cu K  AMP Cu K  AMPALS 502
Resolution range (A ˚ ) 50–2.00 (2.05–2.00) 50–1.85 (1.90–1.85) 50–1.27 (1.30–1.27) 50–1.70 (1.74–1.70) 50–1.70 (1.74–1.70) 50–1.60 (1.64–1.60)
Rcryst† 0.242 (0.226) 0.181 (0.213) 0.107 (0.152) 0.140 (0.163) 0.164 (0.174) 0.144 (0.223)
Rfree† 0.295 (0.281) 0.228 (0.266) 0.134 (0.203) 0.168 (0.206) 0.196 (0.211) 0.168 (0.260)
R.m.s.d. bonds (A ˚ ) 0.017 0.023 0.018 0.013 0.015 0.015
R.m.s.d. angles ( ) 1.65 1.94 1.87 1.52 1.64 1.65
Protein atoms 2116 2116 2110 2118
Nonprotein atoms 380 381 344 344
Mean B factor (A ˚ 2) 9.85 8.13 10.4 10.6
Residues in favored region 243 [98%] 251 [97%] 248 [96%] 253 [98%]
Residues in allowed region 4 [1.4%] 6 [2.3%] 9 [3.5%] 5 [1.9%]
Residues in disallowed region 1 [0.4%] 1 [0.4%] 1 [0.4%] 1 [0.4%]
MolProbity score [percentile] 1.92 [92nd] 1.27 [98th] 1.38 [96th] 1.08 [99th]
PDB code n/a n/a 3md7 3py6 3py5 3qh8
† Rcryst =
P
hkl
   jFobsj j Fcalcj
   =
P
hkl jFobsj. The free R factor was calculated with an equivalent equation using 5% of the reﬂections that were omitted from the reﬁnement.BrabA.11339.a readily crystallized in a well diffracting C-centered
orthorhombic crystal form. The structure could not be solved by
molecular replacement. SSGCID’s ﬁrst approach to obtaining
experimental phases is quick soaks with iodide (Abendroth et al.,
2010, 2011), following the ideas of Nagem and Dauter (Nagem et al.,
2001). The principles behind this approach are (i) the strong anom-
alous signal of iodide at Cu K  X-ray wavelength (f00 = 6.8; Bricogne
et al., 2003), (ii) the compatibility of iodide with weak binding sites
of different natures, both hydrophobic and basic, and (iii) the high
concentrations of iodide that a crystal lattice can tolerate. In the
SSGCID context, this experimental phasing strategy has been
extremely successful (Abendroth et al., 2010, 2011). For
BrabA.11339.a the phasing information was not only obtained from
iodide ions: two metal ions in the active site and a potassium ion
contributed in addition to the iodide ions. In fact, the high-resolution
native data set was collected on a beamline which was optimized for
data collection at the Se edge (0.9774 A ˚ ). The minor anomalous
signal from these three anomalous scatterers was strong enough to
phase the structure independently. The structure solution of
BrabA.11339.a underlines the power of anomalous phasing by both
intrinsic anomalous scatterers such as metals and externally added
scatterers such as iodide.
BrabA.11339.a crystallizes with one monomer per asymmetric unit.
A dimer is formed by crystallographic symmetry (Fig. 1). The dimer
buries 1444 A ˚ 2 accessible surface per protomer in the interface
as calculated by PISA (Krissinel & Henrick, 1997). BrabA.11339.a
assumes a metallo- -lactamase-like fold with two central  -sheets
(Fig. 2). A search for structural homology using SSM (Krissinel &
Henrick, 2004) reveals as the closest structural homologs the PhnP
protein (PDB entry 3g1p, 1.7 A ˚ r.m.s.d., 25% sequence identity), a
putative ribonuclease (PDB entry 1zkp, 1.9 A ˚ r.m.s.d., 21% sequence
identity; Midwest Center for Structural Genomics, unpublished work)
and ribonuclease Z (PDB entry 1y44, 2.3 A ˚ r.m.s.d., 21% sequence
identity; de la Sierra-Gallay et al., 2005) (see Fig. 2). The structural
homology is focused mostly around the central  -sheets and the
helices  4 and  5, while there is more structural variety between
 -strands  5 and  6.
As a very typical feature of  -lactamase-like proteins and the
phosphodiesterase protein family, a two-metal center is present in the
active site of BrabA.11339.a (Fig. 3). The two metals are 3.40 A ˚ apart,
bridged by water 330 and liganded by several histidine residues
(His86, His88, His170 and His241) with bond distances between 2.22
and 2.24 A ˚ , aspartate residues (Asp90 and Asp188) with bond
distances between 2.28 and 2.31 A ˚ and the phosphate group of GMP.
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Figure 2
Fold comparison. Comparison of the fold of BrabA.11339.a with its structural homologues. 3g1p is the PhnP protein from E. coli, 1zkp is a putative ribonuclease from
B. anthracis and 1y44 is ribonuclease Z from B. subtilis. The structural homology is focused around the two  -sheets and helices  4 and  5. Color scheme: Mn, magenta; Zn,
cyan; Na, green; K, blue
Figure 1
Structure of BrabA.11339.a dimer. In the ribbon representation of the crystallo-
graphic dimer the  -strands for each protomer are colored slightly differently. The
crystallographic dyad runs vertically. Various ions are shown as spheres: Mn
2+ in
magenta, K
+ in blue and Na
+ in green. Five strong iodide sites are shown as orange
spheres for one protomer. GMP and tartrate are shown as stick models.The bond distances around the metal center are summarized in
Table 3. They fall within the distances expected for the coordination
of manganese ions (Zheng et al., 2008).
Podzelinska et al. (2009) have performed a detailed functional
analysis of the metal-dependency of PhnP; they report a strong
preference for Mn
2+ and Ni
2+ (Podzelinska et al., 2009) and model the
metals as manganese ions in their structure. In the 1zkp structure of
a putative ribonuclease (Midwest Center for Structural Genomics,
unpublsihed work) the metals are modeled as Zn
2+ ions, likely
because of the presence of zinc chloride in the crystallization buffer.
In the structure of RNAse Z (PDB entry 1y44) the metals are
modeled as Zn
2+ ions because of functional studies, even though this
is not further discussed in the structure paper and the B factors of the
metal ions are higher than for the protein environment (de la Sierra-
Gallay et al., 2005).
The iodide data set already indicated signiﬁcant anomalous density
for the two active-site metals and the potassium site. In order to
analyze the metal center in more detail, diffraction data sets with high
multiplicity were collected at long X-ray wavelengths from the ligand
co-crystals: in-house at   = 1.5418 A ˚ and at the synchrotron at
  = 1.3476 A ˚ . Anomalous Fourier peak heights for the metal sites are
summarized in Table 4(a) and are compared with the theoretical f00
coefﬁcients for various atoms in Table 4(b). Potassium was part of the
crystallization, soaking and cryobuffer at high concentrations that
were consistent between the data sets. The occupancy of the potas-
sium ion can therefore assumed to be constant and can be considered
as a reference. Interestingly, the potassium-ion site is not conserved
between the structural homologs. For both long-wavelength data sets
and the Se-edge data set strong anomalous Fourier peaks can be
observed for the two active-site metals. Each of the peaks is about
four times as strong as the signal for potassium. Manganese is the
only metal in question that has a signiﬁcant anomalous signal at all
three wavelengths. The anomalous signal for Zn
2+ is strong at the
Se edge, but is very weak at either of the longer wavelengths. The
anomalous signal for Ni
2+ is strong at the Se edge and at 1.3476 A ˚ ;
however, it is low at 1.5418 A ˚ . The bond distances between the metals
are in the range expected for Mn
2+ ions (Zheng et al., 2008). There-
fore, the dinuclear center of BrabA.11339.a can be assigned as two
manganese ions with a high degree of conﬁdence.
In the native structure, a partially occupied GMP molecule can be
observed in the immediate proximity of the binuclear Mn
2+ center.At
no stage during the puriﬁcation was GMP added to the protein; thus,
it must have been copuriﬁed from the expression host. In order to
conﬁrm the binding of nucleotides, crystals were grown in the
presence of GMPPNP and AMPPNP. In both cases, however, very
solid electron density could be observed for GMP and AMP,
respectively (see Fig. 4). The  -phosphate group is very well deﬁned,
while there is no density for the  -phosphate or  -phosphate groups.
The  -phosphate groups of GMPPNP or AMPPNP, which had been
added during crystal growth and had been supplemented for a short
soak in the cryobuffer, are nonhydrolyzable; the  -phosphate groups,
however, can be hydrolyzed. It can be assumed that BrabA.11339.a is
able to hydrolyze AMPPNP and GMPPNP between the  -phosphate
and the  -phosphate to AMP or GMP, respectively.
The GMPor AMP molecules are bound in the dimer interface and
make multiple interactions. The phosphate group is involved in
hydrogen bonds to both manganese ions, the bridging water molecule
330 (called water 1 in the ligand-bound structures), histidine residues
His88 and His241, aspartate residue Asp90 and further water mole-
cules (315, 454 and 511 in the high-resolution structure). The ribose
group makes two interactions with the carboxyl group of Asp96 (O2*
and O3*) and two interactions with the guanidine group of Arg99
(O2*), each from the other protomer. The guanine group stacks with
Tyr127 from the other protomer. The guanine moiety engages in
structural communications
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Figure 3
Dinuclear manganese center. The active site of BrabA.11339.a consists of two
manganese ions (magenta), which are bridged by a water molecule (red). The
phosphate group of GMP is in close proximity to this activated water molecule. The
 A-weighted 2Fo   Fc electron density for the high-resolution data set is contoured
at 1  (blue) and the corresponding Fo   Fc electron density is contoured at  3 
(green/red). The anomalous Fourier electron density is contoured at 10  (orange).
The strong anomalous Fourier density at all three wavelengths indentiﬁes the
active-site metal as manganese. For bond distances refer to Table 3; for anomalous
peak heights refer to Table 4.
Table 3
Bond distances of the dinuclear Mn
2+ center for the high-resolution data set.
Atom Distance from Mn300 (A ˚ ) Atom Distance from Mn301 (A ˚ )
Mn301 3.40 Mn300 3.40
Wat330 2.10 Wat330 2.07
GMP O1P 2.38 GMP O3P 2.20
Asp90 OD2 2.28
Asp188 OD2 2.28 Asp188 OD2 2.31
Asp188 OD1 3.00
His241 NE2 2.23 His86 NE2 2.24
His88 ND1 2.22
His170 NE2 2.22
Table 4
Anomalous Fourier peak heights and Fourier coefﬁcients.
(a) Anomalous Fourier maps were calculated over the full resolution range for all three
data sets. Peaks were found with the CCP4 program PEAKMAX.
Atom 0.9774 A ˚ 1.3476 A ˚ Cu K  AMP Cu K  GMP
Mn300 33.8 31.8 36.6 45.8
Mn301 42.4 42.1 40.5 47.2
K302 8.8 12.6 11.7 14.3
Cys15 SG 6.4 5.7 7.2 9.0
Cys31 SG 6.5 4.9 8.3 10.0
Met71 SD 5.7 8.3 9.2 9.9
Met109 SD 6.7 6.6 7.3 7.9
Cys128 SG 5.3 5.1 8.0 10.3
Met143 SD 5.0 6.0 5.7 5.4
Cys186 SG 6.5 5.5 7.5 9.3
Met242 SD 6.1 7.3 8.3 10.4
Met252 SD — — 5.9 5.6
(b) Anomalous Fourier coefﬁcients f 00 (e
 ) for selected elements at Cu K  wavelength
and 12.4 keV are listed for comparison (Bricogne et al., 2003). Manganese is the only
metal in question that has a stronger signal than potassium at both wavelengths.
0.9774 A ˚ 1.3476 A ˚ 1.5418 A ˚
I 3.18 5.49 6.83
S 0.23 0.43 0.56
Mn 1.30 2.26 2.80
Zn 2.48 0.55 0.71
K 0.46 0.84 1.08
Ni 1.95 3.30 0.51hydrogen bonds to the amide N atom of Ala89 (N3) and to water
molecules. Neither of these interactions should be able to provide
speciﬁcity for either AMP or GMP.
In the PhnP structure (PDB entry 3g1p), a malonate is modelled in
the space that is occupied by the phosphate and the ribose. No ligand
was modelled in the putative ribonuclease (PDB entry 1zkp). In the
structure of ribonuclease Z from B. subtilis (PDB entry 1y44, r.m.s.d.
2.3–2.4 A ˚ , 20% sequence identity) a phosphate ion is modelled in an
identical location to the phosphate group of GMP in BrabA.11339.a,
even though the B factors for the phosphate ion are signiﬁcantly
higher than those for the environment (de la Sierra-Gallay et al.,
2005). None of these three homologous structures are able to
accommodate a GMP or an AMP molecule in the conformation
observed in BrabA.11339.a without conformational changes.
The discovery of a purine monophosphate in the vicinity of the
dinuclear manganese center allows speculation regarding the func-
tion of BrabA.11339.a. For various enzymes with a dinuclear center it
is known that the bridging water is activated by the two metal ions.
The water reacts as a hydroxide, starting a hydrolytic reaction. The
phosphate group of the GMPor AMP is located in close proximity to
this deprotonated water molecule 303 (2.2 A ˚ ). There is enough space
in the active site to ﬁt two more phosphate groups. It therefore seems
likely that BrabA.11339.a is a GTP/ATP or GDP/ADP hydrolase.
The genetic context of BrabA.11339.a (BAB1_1016) hints at a
function in nucleotide processing. Its genetic neighbors are
BAB1_1012, DNA polymerase II subunit ; BAB1_1013, a hypo-
thetical protein; BAB1_1014, metG, a methionyl-tRNA synthetase;
BAB_1015, a TatD-related deoxyribonuclease; BAB1_1016,
BrabA.11339.a; BAB1-1017, a cyclic  -1,2-glucan ABC transporter;
BAB1_1018, a hypothetical protein; and BAB1_1019, an RNA-
binding S4:pseudouridine synthase.
The structure of BrabA.11339.a and its binuclear manganese
center were determined with high accuracy using high-resolution data
and anomalous diffraction. The initially serendipitous discovery of
GMP in the active site and the subsequent high-resolution co-crystal
structures with in situ hydrolyzed AMP or GMP shed light on the
function of this protein, which entered the SSGCID pipeline as a
‘ -lactamase-like protein’. Further analysis will be needed to validate
the biological function of this protein and its suitability for structure-
guided drug design against the pathogen B. melitensis.
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